Arix Bioscience (LON:ARIX) Trading Down 1.6%

Shares of Arix Bioscience plc (LON:ARIXGet Rating) dropped 1.6% during trading on Thursday . The company traded as low as GBX 110.01 ($1.35) and last traded at GBX 110.50 ($1.36). Approximately 41,287 shares traded hands during trading, a decline of 72% from the average daily volume of 149,721 shares. The stock had previously closed at GBX 112.25 ($1.38).

The stock’s fifty day moving average price is GBX 113.31 and its 200 day moving average price is GBX 117.81. The stock has a market cap of £141.51 million and a P/E ratio of -2.29. The company has a current ratio of 85.04, a quick ratio of 84.95 and a debt-to-equity ratio of 0.05.

About Arix Bioscience (LON:ARIX)

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences.

Recommended Stories

Receive News & Ratings for Arix Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arix Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.